Abstract
The epigenetic alteration is widely understood as the key to cancer initiation. Herein, we intended to clarify the role of transcription factor 3 (TCF3) in the development of glioma and the behind epigenetic mechanism. Through bioinformatics analysis, we identified a TCF3-DNA methyltransferase 1 (DNMT1)-secreted frizzled related protein 1 (SFRP1) axis which was differentially expressed and interacted in gliomas. More specifically, TCF3 activated DNMT1 transcription, and DNMT1 repressed SFRP1 expression. TCF3 and DNMT1 were overexpressed, while SFRP1 was downregulated in glioma. Functionally, TCF3 silencing inhibited cell proliferation and migration, and promoted apoptosis, which were reversed by DNMT1. SFRP1 inhibited the tumor supporting effects of DNMT1 on glioma cells. Moreover, TCF3 downregulation or SFRP1 overexpression inhibited tumorigenesis and enhanced apoptosis of glioma cells, while DNMT1 enhanced tumorigenesis and repressed apoptosis in tumor tissues in vivo. The Wnt pathway was a downstream effector of the TCF3-DNMT1-SFRP1 axis. Collectively, this study determined a novel therapeutic target TCF3 for glioma from the perspective of epigenetic alteration via regulation of SFRP1 expression in a DNMT1-dependent manner.
Similar content being viewed by others
References
Arce L, Yokoyama NN, Waterman ML (2006) Diversity of LEF/TCF action in development and disease. Oncogene 25:7492–7504. https://doi.org/10.1038/sj.onc.1210056
Bao Z, Wang Y, Wang Q, Fang S, Shan X, Wang J, Jiang T (2021) Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution. Front Med 15:551–561. https://doi.org/10.1007/s11684-020-0760-2
Campbell PM, Szyf M (2003) Human DNA methyltransferase gene DNMT1 is regulated by the APC pathway. Carcinogenesis 24:17–24. https://doi.org/10.1093/carcin/24.1.17
Chakraborty B et al (2021) Differential Wnt-beta- catenin pathway activation in HPV positive and negative oral epithelium is transmitted during head and neck tumorigenesis: clinical implications. Med Microbiol Immunol 210:49–63. https://doi.org/10.1007/s00430-020-00697-9
Chiaro C, Lazarova DL, Bordonaro M (2012) Tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells. Biochem Biophys Res Commun 428:121–126. https://doi.org/10.1016/j.bbrc.2012.10.018
Darwiche N (2020) Epigenetic mechanisms and the hallmarks of cancer: an intimate affair Am. J Cancer Res 10:1954–1978
Hrckulak D, Kolar M, Strnad H, Korinek V (2016) TCF/LEF transcription factors: an update from the internet resources. Cancers (Basel). https://doi.org/10.3390/cancers8070070
Jia H, Wu D, Zhang Z, Li S (2020) TCF3-activated FAM201A enhances cell proliferation and invasion via miR-186–5p/TNKS1BP1 axis in triple-negative breast cancer. Bioorg Chem 104:104301. https://doi.org/10.1016/j.bioorg.2020.104301
Kafka A, Karin-Kujundzic V, Serman L, Bukovac A, Njiric N, Jakovcevic A, Pecina-Slaus N (2018) Hypermethylation of Secreted Frizzled Related Protein 1 gene promoter in different astrocytoma grades. Croat Med J 59:213–223
Li R, Li Y, Hu X, Lian H, Wang L, Fu H (2016) Transcription factor 3 controls cell proliferation and migration in glioblastoma multiforme cell lines. Biochem Cell Biol 94:247–255. https://doi.org/10.1139/bcb-2015-0162
Liu J et al (2018) Methylation of secreted frizzled-related protein 1 (SFRP1) promoter downregulates Wnt/beta-catenin activity in keloids. J Mol Histol 49:185–193. https://doi.org/10.1007/s10735-018-9758-3
Llaguno-Munive M, Vazquez-Lopez MI, Jurado R, Garcia-Lopez P (2021) Mifepristone repurposing in treatment of high-grade gliomas front. Oncol 11:606907. https://doi.org/10.3389/fonc.2021.606907
Luo L, Zhang H, Nian S, Lv C, Ni B, Wang D, Tian Z (2017) Up-regulation of transcription factor 3 is correlated with poor prognosis in cervical carcinoma. Int J Gynecol Cancer 27:1422–1430. https://doi.org/10.1097/IGC.0000000000001032
Ma J et al (2017) RNAi-mediated TCF-3 gene silencing inhibits proliferation of Eca-109 esophageal cancer cells by inducing apoptosis. Biosci Rep. https://doi.org/10.1042/BSR20170799
Majchrzak-Celinska A, Slocinska M, Barciszewska AM, Nowak S, Baer-Dubowska W (2016) Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival. J Appl Genet 57:189–197. https://doi.org/10.1007/s13353-015-0312-7
Miao CG et al (2015) DNMT1 activates the canonical Wnt signaling in rheumatoid arthritis model rats via a crucial functional crosstalk between miR-152 and the DNMT1, MeCP2. Int Immunopharmacol 28:344–353. https://doi.org/10.1016/j.intimp.2015.06.013
Mweempwa A, Rosenthal MA, Dimou J, Drummond KJ, Whittle JR (2021) Perioperative clinical trials for glioma: Raising the bar. J Clin Neurosci 89:144–150. https://doi.org/10.1016/j.jocn.2021.04.026
Nagarajan RP, Costello JF (2009a) Epigenetic mechanisms in glioblastoma multiforme. Semin Cancer Biol 19:188–197. https://doi.org/10.1016/j.semcancer.2009.02.005
Nagarajan RP, Costello JF (2009b) Molecular epigenetics and genetics in neuro-oncology. Neurotherapeutics 6:436–446. https://doi.org/10.1016/j.nurt.2009.04.002
Quan H et al (2014) Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition. Oncogene 33:2826–2835. https://doi.org/10.1038/onc.2013.225
Schiefer L et al (2014) Epigenetic regulation of the secreted frizzled-related protein family in human glioblastoma multiforme. Cancer Gene Ther 21:297–303. https://doi.org/10.1038/cgt.2014.30
Shen X et al (2017) The increased expression of TCF3 is correlated with poor prognosis in Chinese patients with nasopharyngeal carcinoma. Clin Otolaryngol 42:824–830. https://doi.org/10.1111/coa.12834
Slyper M et al (2012) Control of breast cancer growth and initiation by the stem cell-associated transcription factor TCF3. Cancer Res 72:5613–5624. https://doi.org/10.1158/0008-5472.CAN-12-0119
Wang K, Xie D, Xie J, Wan Y, Ma L, Qi X, Yang S (2015) MiR-27a regulates Wnt/beta-catenin signaling through targeting SFRP1 in glioma. NeuroReport 26:695–702. https://doi.org/10.1097/WNR.0000000000000410
Wu R, Yun Q, Zhang J, Bao J (2019) Downregulation of KLF13 through DNMT1-mediated hypermethylation promotes glioma cell proliferation and invasion. Onco Targets Ther 12:1509–1520. https://doi.org/10.2147/OTT.S188270
Xing Z, Ni Y, Zhao J, Ma X (2017) Hydrogen peroxide-induced secreted frizzled-related protein 1 gene demethylation contributes to hydrogen peroxide-induced apoptosis in human U251 glioma cells. DNA Cell Biol 36:347–353. https://doi.org/10.1089/dna.2016.3594
Yu H, Zhang S, Ibrahim AN, Wang J, Deng Z, Wang M (2019) RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1. Biochem Biophys Res Commun 516:999–1006. https://doi.org/10.1016/j.bbrc.2019.06.097
Zhang J, Yang C, Wu C, Cui W, Wang L (2020) DNA methyltransferases in cancer: biology, paradox, aberrations, and targeted therapy. Cancers (Basel). https://doi.org/10.3390/cancers12082123
Zheng L, Hu N, Zhou X (2019) TCF3-activated LINC00152 exerts oncogenic role in osteosarcoma through regulating miR-1182/CDK14 axis. Pathol Res Pract 215:373–380. https://doi.org/10.1016/j.prp.2018.12.031
Zhou D et al (2015) DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells. Exp Mol Med 47:e182. https://doi.org/10.1038/emm.2015.57
Funding
This work was supported by Doctor Start-up Fund (No. BSQDJ0130), Provincial Discipline Leader Class C (No. DTRC18018) and Stereotactic Brain Electrode Placement and EEG Detection in Patients With Refractory Epilepsy (No. FCJS202040).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zeng, W., Jiang, H., Wang, Y. et al. TCF3 Induces DNMT1 Expression to Regulate Wnt Signaling Pathway in Glioma. Neurotox Res 40, 721–732 (2022). https://doi.org/10.1007/s12640-022-00510-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-022-00510-w